Regarding the text "Marinović credited private Medicalana", published in "Vijesti", the director of "Montefarm" reacted Goran Marinović. We transmit the reaction in its entirety:
"With this response, I want to clarify to the interested public that assignment is a common way of doing business in the financial sphere and that this type of assignment - sale of receivables does not require the consent of the debtor. In 2021, a contract was signed with wholesaler Glosarij DOO and ERSTE Bank (factor) in the value of 15 million euros and with Farmont DOO and IRF (factor) in the value of over 784.000 euros. In 2022, a contract was signed with Farmont DOO and Erste Bank in the amount of approx. 900 thousand euros and a cession with Medicalana in the amount of 80 thousand euros. During 2023, an assignment was signed with Medicalana in the amount of 130.000 euros. Therefore, during 2021, 2022 and 2023, contracts on the transfer - sale of receivables in the amount of approx. 16,6 million euros were signed with the mentioned companies, and 210.000 euros with the famous Medicalana. Therefore, Medicalana's participation in the mentioned financial operations in the previous three years (2021, 2022 and 2023) is 1,2 percent. The question arises, what did Montefarm get with this? The answer is simple, instead of paying obligations to suppliers once within 90 days, the payment deadline was extended to 180 days without any costs to Montefarm, which increased the company's level of liquidity and increased the ability to react in emergency situations in the provision of medicines and other of medical and non-medical materials in healthcare, in order to prevent possible blockages in the delivery of medicines by suppliers.
Regarding advance payments and payments before the due date, the standard practice since the beginning of my mandate is that state funds are not kept in an account, but that urgent payments are made to the most important suppliers in order to improve their liquidity and thus prevent blockages in the delivery of the necessary medicines, i.e. stability of drug supply. I will cite as an example the obligations for February 2024, where the obligations to suppliers amounted to over 9 million, and by 27 February 2, over 2024 million euros were paid to the largest suppliers. So, with over 15 million euros, obligations that are due only at the end of March were paid in advance, which increased the liquidity of suppliers, ZUACG Montefarm will achieve certain credit ratings, enable a stable supply of medicines, medical and non-medical equipment, while the state avoided hoarding funds that would have been in the accounts Montefarma until the expiration date. This advance of 6 million was paid to the largest suppliers, i.e. Glossary, Farmegra, wholesaler Medica and so on. All payments to small suppliers, which includes Medicalana, do not even represent 6 percent of total payments to large suppliers, thus maintaining the stability of the supply of the health care system of Montenegro.
This conduct of business policy resulted in Montefarm closing the year 2022 and 2023 without any debts to suppliers, and the turnover from own funds increased from approx. 1,7 million to approx. 8,5 million, markets (cash) from approx. 2,4 million to approx. 10,2 million, and the net profit increased from approx. 350.000 to over one million euros on an annual average. In the end, the question arises, how can such financial results come from the improper operations of Montefarma? Therefore, if 'Marinović lent private Medicalana', what can we say about the 'millions in lending to the above-mentioned private wholesalers'?"
Bonus video:
